EYLEA^® (aflibercept) Injection, ARCALYST^® (rilonacept), and
ZALTRAP^® (ziv-aflibercept) Injection for Intravenous Infusion exemplify Regeneron's commitment to discover, invent, develop, manufacture, and commercialize important medicines for patients suffering from serious diseases.

More information on EYLEA Full U.S. Prescribing Information for EYLEA

More information on ARCALYST Full U.S. Prescribing Information for ARCALYST

More information on ZALTRAP Full U.S. Prescribing Information for ZALTRAP Including Boxed WARNING

The product information in this site is intended only for residents of the United States. The products discussed herein may have different product labeling in different countries.